{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:31:04Z","timestamp":1781523064069,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.transproceed.2019.04.050","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T10:04:52Z","timestamp":1561629892000},"page":"1816-1821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gout Severity in Recipients of Kidney Transplant"],"prefix":"10.1016","volume":"51","author":[{"given":"Mark D.","family":"Brigham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren P.","family":"Radeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive M.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"LaMoreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.04.050_bib1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American college of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.transproceed.2019.04.050_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American college of rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.transproceed.2019.04.050_bib3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.tp.0000188722.84775.af","article-title":"New-onset gout after kidney transplantation: Incidence, risk factors and implications","volume":"80","author":"Abbott","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.04.050_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0272-6386(87)80103-8","article-title":"The incidence of gout in renal transplant recipients","volume":"10","author":"West","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.04.050_bib5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/TP.0b013e31818b22ed","article-title":"Gout in renal allograft recipients according to the pretransplant hyperuricemic status","volume":"86","author":"Hern\u00e1ndez-Molina","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.04.050_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","article-title":"Cyclosporine-induced hyperuricemia and gout","volume":"321","author":"Lin","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.050_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(85)91166-3","article-title":"Gout and hyperuricaemia in patients on cyclosporin and diuretics","volume":"1","author":"Tiller","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.04.050_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00007890-199107000-00013","article-title":"Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use","volume":"52","author":"Noordzij","year":"1991","journal-title":"Transplantation"},{"issue":"Suppl 10","key":"10.1016\/j.transproceed.2019.04.050_bib9","article-title":"Prevalence of gout in the surviving U.S. solid organ transplant population [abstract]","author":"Brigham","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2019.04.050_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2019.04.050_bib11","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2019.04.050_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semnephrol.2004.09.008","article-title":"Uric acid and transplantation","volume":"25","author":"Mazzali","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000188609","article-title":"Impairment of tubular secretion of urate in renal transplant patients on cyclosporine","volume":"70","author":"Marc\u00e9n","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2019.04.050_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000045219","article-title":"Glomerular and tubular function in renal transplant patients treated with and without cyclosporine A","volume":"80","author":"Hansen","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2019.04.050_bib15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","article-title":"Renal transplant-associated hyperuricemia and gout","volume":"11","author":"Clive","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7182\/pit2015322","article-title":"Hyperuricemia and gout in solid-organ transplant: update in pharmacological management","volume":"25","author":"Sullivan","year":"2015","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2019.04.050_bib17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1600-6143.2011.03613.x","article-title":"Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis","volume":"11","author":"Haririan","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.04.050_bib18","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.transproceed.2005.08.042","article-title":"Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients","volume":"37","author":"Kanbay","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.04.050_bib19","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1681\/ASN.2007111256","article-title":"Association of incident gout and mortality in dialysis patients","volume":"19","author":"Cohen","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10067-006-0292-4","article-title":"Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study","volume":"26","author":"Chen","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2019.04.050_bib22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3899\/jrheum.170555","article-title":"Crystal-proven gout and characteristic gout severity factors are associated with cardiovascular disease","volume":"45","author":"Disveld","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3899\/jrheum.071229","article-title":"Quality of life and disability in patients with treatment-failure gout","volume":"36","author":"Becker","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib24","first-page":"86","article-title":"Enthesopathy and atypical gouty arthritis following renal transplantation: a case control study","volume":"62","author":"Cohen","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2019.04.050_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.6002\/ect.mesot2014.P112","article-title":"Dermal tophus: a complication of gout in a kidney transplant recipient","volume":"13","author":"Ayvazoglu Soy","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2019.04.050_bib26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/art.1780371124","article-title":"Proximal gout following renal transplantation","volume":"37","author":"Cohen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2019.04.050_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.050_bib28","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/rheumatology\/kep088","article-title":"Febuxostat: a new treatment for hyperuricaemia in gout","volume":"48","author":"Edwards","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.transproceed.2019.04.050_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-95-5-588","article-title":"Allopurinol hepatotoxicity. Report of 2 cases and review of the literature","volume":"95","author":"Al-Kawas","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2019.04.050_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11926-009-0019-z","article-title":"A\u00a0critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout","volume":"11","author":"Chao","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.transproceed.2019.04.050_bib31","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.050_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.1990.tb00195.x","article-title":"Azathioprine and allopurinol: a potentially dangerous combination","volume":"228","author":"Venkat Raman","year":"1990","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.transproceed.2019.04.050_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.26.2.136","article-title":"Allopurinol in the treatment of uraemic patients with gout","volume":"26","author":"Wilson","year":"1967","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2019.04.050_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2215\/CJN.08280816","article-title":"Risk of febuxostat-associated myopathy in patients with CKD","volume":"12","author":"Liu","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of gout and hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.04.050_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.HYP.17.2.194","article-title":"Nephrotoxicity of allopurinol is enhanced in experimental hypertension","volume":"17","author":"Trachtman","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.transproceed.2019.04.050_bib37","first-page":"221","article-title":"Allopurinol-induced nephrotoxicity: protection by the antioxidant, butylated hydroxytoluene","volume":"75","author":"Ansari","year":"1992","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.transproceed.2019.04.050_bib38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2019.04.050_bib39","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jamainternmed.2018.4463","article-title":"Association of chronic kidney disease with allopurinol use in gout treatment","volume":"178","author":"Vargas-Santos","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.transproceed.2019.04.050_bib40","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar3806","article-title":"Risk of end-stage renal disease associated with gout: a nationwide population study","volume":"14","author":"Yu","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.transproceed.2019.04.050_bib41","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519304609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519304609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:30:46Z","timestamp":1758576646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519304609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0041134519304609"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.050","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gout Severity in Recipients of Kidney Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}